)
Philip Wills
Chief Commercial Officer,
Catalent
Sessions
-
04-Sep-2025Workshop: Key considerations for late-phase and commercial AAV gene therapy manufacturing
-
10-Feb-2026Phacilitate.TV StudioBreaking the Bottleneck: Solving Late-Stage AAV Challenges with Real World Commercial Experience
-
10-Feb-2026Theatre 4The Hunger Games: Selecting the right outsourcing partner in the new era of advanced therapies